Socioeconomic differences in Swedish children and adolescents injured in road traffic incidents: cross sectional study.

Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 1998;351:637-41. 2 Taylor B, Miller E, Farrington CP, Petropoulos M-C, Favot-Mayaud I, Li J, et al. Autism and measles, mump and rubella vaccine: no epidemiological evidence for a causal association. Lancet 1999;353:2026-9. 3 Farrington CP, Miller E, Taylor B. MMR and autism: further evidence against a causal association. Vaccine 2001;19:3632-5. 4 Kaye JA, Melero-Montes M, Jick H. Mumps, measles and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis. BMJ 2001;322:460-3. 5 Dales L, Hammer S, Smith N. Time trends in autism and MMR immunisation in California. JAMA 2001;285:1183-5. 6 DeWilde S, Carey IM, Richards S, Hilton SR, Cook DG. Do children who become autistic consult more often after MMR vaccination? Brit J Gen Pract 2001;51:226-7. 7 Wakefield AJ. Testimony to the Congress of the United States House of Representatives Committee on Government Reform: hearing on the challenges of autism. Why the increased rates? A one year update. Washington. April 2001. www.house.gov/reform/hearings/healthcare/ 01.04.25/wakefield.htm. [accessed 7 February 2002] 8 Kurita H, Kita M, Miyaka A. A comparative study of development and symptoms among disintegrative psychosis and infantile autism with and without speech loss. J Autism Dev Disord 1992;22:175-88. 9 Fombonne E, Chakrabarti S. No evidence for a new variant of measles-mumps-rubella-induced autism. Pediatrics 2001;108:e58. 10 Wakefield A, Anthony A, Murch S, Thomson M, Montgomery SM, Davies S, et al. Enterocolitis and immunodeficiency in children with developmental disorders. Am J Gastroenterol 2000;95:2285-95. 11 Furlano RI, Anthony A, Day R, Brown A, McGarvey L, Thomson MA, et al. Colonic CD8 and ãd T-cell infiltration with epithelial damage in children with autism. J Pediatr 2001;138:366-72. 12 Gershon M. Testimony to the Congress of the United States House of Representatives Committee on Government Reform: hearing on the challenges of autism. Why the increased rates? A one year update. Washington. April 2001. www.house.gov/reform/hearings/healthcare/ 01.04.25/gershon.htm. [accessed 8 February 2002] 13 Halsey NA, Hyman SL. Conference writing panel. Measles-mumpsrubella vaccine and autistic spectrum disorder: report from the new challenges in childhood immunizations conference convened in Oak Brook, Illinois, Jun 12-13, 2000. Pediatrics 2001;107(5):1-23. www.pediatrics.org/ cgi/content/full/107/5/e84. 14 Lord C, Rutter M, Le Couteur A. Autism diagnostic interview-revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord 1994;24:659-85.